Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: RLS (USA) INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-10-01 to 2025-09-30
Current total value of award: $204216.35
Description: RADIOPHARMACEUTICAL